European Commission authorises first safe and effective vaccine against COVID-19

Published on December 20, 2020

European Commission Press release Brussels, 21 Dec 2020 Today, the European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by BioNTech and Pfizer, making it the first COVID-19 vaccine authorised in the EU.

Other news

EIB and CAF fund climate action projects to boost jobs and competitiveness

December 18, 2020
The COVID-19 pandemic has exposed the need for international cooperation to mitigate its adverse effects and to promote well-being and economic and social revival of countries when they need it most, with climate action as a key criterion for interventions. CAF—development bank of Latin America—and the EIB are capitalising on their complementary strengths to underpin sustainable development and in

EIB and ProCredit unlock €65 million to speed the recovery of small and medium sized companies in the Western Balkans from the COVID-19 crisis

December 21, 2020
The EIB and the ProCredit group have agreed on a new €65 million credit line to support small and medium enterprises (SMEs) in the Western Balkans and to speed their recovery from the COVID-19 crisis. This transaction provides much-needed financing to companies in Serbia, Albania, North Macedonia and Bosnia & Herzegovina and addresses their working capital, liquidity and investment needs in the fa